Doogan Declan
Director at Biohaven Pharmaceutical Holding Co Ltd.
- Sold, on record
- $58.1M
- Dollars the filings state
- Form 4 sales
- 15
- Latest Nov 29, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.Plan not statedFeb 26, 2019 2019
Sold 76,898 shares at $44.90 ($3.5M)
Doogan Declan, Director
Sold 16.1% of holdings ($21.5M position)400,958 shares left0.9x usual sizeFiling
- 2 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.Plan not statedMar 1, 2019 +3 days
Sold 101,024 shares at $46.26 ($4.7M)
Doogan Declan, Director
Sold 21.3% of holdings ($22M position)373,913 shares left1.2x usual sizeFiling
- 3 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.Plan not statedMar 26, 2019 +25 days
Sold 11,175 shares at $53.69 ($600k)
Doogan Declan, Director
Sold 1.1% of holdings ($55.1M position)1M shares left0.1x usual sizeFiling
- 4 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.Plan not statedApr 16, 2019 +21 days
Sold 88,825 shares at $58.42 ($5.2M)
Doogan Declan, Director
Sold 8.8% of holdings ($59.3M position)926,002 shares left1.1x usual sizeFiling
- 5 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.UnusualJun 12, 2020 +423 days
Sold 160,000 shares at $64.07 ($10.3M)
Doogan Declan, Director
Sold 17.3% of holdings ($59.3M position)766,002 shares left4x usual sizeFiling
- 6 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.Plan not statedJun 16, 2020 +4 days
Sold 140,000 shares at $67.37 ($9.4M)
Doogan Declan, Director
Sold 18.3% of holdings ($51.6M position)626,002 shares left2.4x usual sizeFiling
- 7 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.Plan not statedNov 16, 2021 +518 days
Sold 37,740 shares at $116.65 ($4.4M)
Doogan Declan, Director
Sold 4% of holdings ($109M position)895,173 shares leftFiling
- 8 Form 4 sale Biohaven Pharmaceutical Holding Co Ltd.Plan not statedNov 29, 2021 +13 days
Sold 24,525 shares at $112.80 ($2.8M)
Doogan Declan, Director
Sold 2.7% of holdings ($101M position)870,648 shares left0.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (15)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 29, 2021 | Dec 1, 2021 | Biohaven Pharmaceutical Holding Co Ltd. | Director | Form 4 sale | 24,525 | $2.8M | 2.7% | Plan not stated | SEC |
| Nov 16, 2021 | Nov 17, 2021 | Biohaven Pharmaceutical Holding Co Ltd. | Director | Form 4 sale | 37,740 | $4.4M | 4.0% | Plan not stated | SEC |
| Jun 16, 2020 | Jun 17, 2020 | Biohaven Pharmaceutical Holding Co Ltd. | Director | Form 4 sale | 140,000 | $9.4M | 18.3% | Plan not stated | SEC |
| Jun 12, 2020 | Jun 12, 2020 | Biohaven Pharmaceutical Holding Co Ltd. | Director | Form 4 sale | 160,000 | $10.3M | 17.3% | Unusual | SEC |
| Apr 16, 2019 | Apr 16, 2019 | Biohaven Pharmaceutical Holding Co Ltd. | Director | Form 4 sale | 88,825 | $5.2M | 8.8% | Plan not stated | SEC |
| Mar 26, 2019 | Mar 26, 2019 | Biohaven Pharmaceutical Holding Co Ltd. | Director | Form 4 sale | 11,175 | $600k | 1.1% | Plan not stated | SEC |
| Mar 1, 2019 | Mar 1, 2019 | Biohaven Pharmaceutical Holding Co Ltd. | Director | Form 4 sale | 101,024 | $4.7M | 21.3% | Plan not stated | SEC |
| Feb 26, 2019 | Feb 26, 2019 | Biohaven Pharmaceutical Holding Co Ltd. | Director | Form 4 sale | 76,898 | $3.5M | 16.1% | Plan not stated | SEC |
| Feb 19, 2019 | Feb 20, 2019 | Biohaven Pharmaceutical Holding Co Ltd. | Director | Form 4 sale | 2,078 | $95k | 0.2% | Plan not stated | SEC |
| Feb 13, 2019 | Feb 14, 2019 | Biohaven Pharmaceutical Holding Co Ltd. | Director | Form 4 sale | 40,000 | $1.8M | 3.5% | Plan not stated | SEC |
| Dec 3, 2018 | Dec 6, 2018 | Biohaven Pharmaceutical Holding Co Ltd. | Director | Form 4 sale | 40,000 | $1.7M | 3.3% | Plan not stated | SEC |
| Jun 5, 2018 | Jun 6, 2018 | Biohaven Pharmaceutical Holding Co Ltd. | Director | Form 4 sale | 89,216 | $3.1M | 6.9% | Plan not stated | SEC |
| Jun 1, 2018 | Jun 1, 2018 | Biohaven Pharmaceutical Holding Co Ltd. | Director | Form 4 sale | 110,784 | $3.9M | 7.9% | Plan not stated | SEC |
| Jan 18, 2018 | Jan 18, 2018 | Biohaven Pharmaceutical Holding Co Ltd. | Director | Form 4 sale | 128,058 | $3.5M | 8.4% | Plan not stated | SEC |
| Jan 12, 2018 | Jan 12, 2018 | Biohaven Pharmaceutical Holding Co Ltd. | Director | Form 4 sale | 121,942 | $3.3M | 9.4% | Plan not stated | SEC |